Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1424966

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1424966

Skin Replacements and Substitutes Market Size and Share Analysis by Product, Class, Application, End User - Global Industry Demand Forecast to 2030

PUBLISHED:
PAGES: 350 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The global skin replacements and substitutes market size is set to be USD 1,869.2 million by 2030, witnessing 7.0% CAGR between 2024 and 2030. This will be due to the increasing number of citizens spending on appearance enhancement, rising incidence of burns, growing rate of road accidents, surging life expectancy, and escalating prevalence of skin and chronic disease. As per the WHO, nearly 1 million people in India get severe and moderate burns each year. The high disability-adjusted life-years in India are due to burns and many other causes.

Increasing Focus on Enhance Appearance of Skin

People with skin damage due to chronic diseases and other reasons are increasingly seeking remedies to enhance their appearance. Further, due to the innovations in the healthcare sector, various products are available for use as skin replacement, such as acellular substitutes; these products are cost-effective and efficient. In these products, a nylon mesh works as the dermis, and a silicon membrane works as the epidermis. It is then implanted into porcine collagen and connected by chemical bonds for attachment to the wound base.

Deep burns can destroy both layers of the skin (dermis and epidermis), exposing them to microorganisms, which can cause infections and further complications. Therefore, quick medical guidance or surgery is advised. Artificial skin, after sterilization, has the capacity to enhance the release of cytokines and growth factors for regenerating the destroyed tissue. The width, orifice, and interconnecting pores of the graft should be ideal for the regeneration of new skin.

Continued Dominance of Wound Care Clinics and Hospitals on Market

Wound care clinics and hospitals are the largest end users as they have sophisticated facilities, expert professionals, necessary medication, and the technology required for complicated burn cases. With an increasing number of people suffering from dermatological diseases, the footfall at these healthcare centers is rising. Moreover, severe wounds are caused after surgery; hence, such skin replacement procedures are often part of the overall post-operative care regimen.

Growing Opportunities in APAC

North America is dominating the market due to the advancements in the healthcare sector and a high demand for skincare. Moreover, the key market players are collaborating with hospitals, cosmetic centers, and wound care clinics to sell and advance their skin replacement and substitute products and pursuing the approval of the FDA for them. For instance, in June 2021 Mallinckrodt Pharmaceuticals received the FDA approval for a novel skin product, called StrataGraft. It can reduce the requirement for autografts if some part of the deeper skin layers and dermal elements remains intact after a thermal burn injury.

APAC is the fastest-growing market due to the increasing demand for cosmetic procedures and the high prevalence of diabetic foot ulcers and other skin issues. Between 15 and 25% of the population with diabetes mellitus would develop a DFU at some point. As per the WHO, diabetic population in China is expected to reach 150 million by 2040 from 110 million in 2016. Moreover, India registered 31 million new diabetes diagnoses in 2019-2021.

Some of the key players in the skin and replacements and substitutes market are Acelity L.P. Inc., MiMedx Group Inc., Organogenesis Inc., Vericel Corporation, FUJIFILM Cellular Dynamics Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, AlloSource, and MatTek Corporation.

Product Code: 11704

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by class
    • 1.4.3. Market size breakdown, by application
    • 1.4.4. Market size breakdown, by end user
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
  • 6.3. Market Revenue, by Class (2017-2030)
    • 6.3.1. Class I market revenue, by type (2017-2030)
    • 6.3.2. Class II market revenue, by type (2017-2030)
    • 6.3.3. Class III market revenue, by type (2017-2030)
  • 6.4. Market Revenue, by Application (2017-2030)
  • 6.5. Market Revenue, by End User (2017-2030)
  • 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
  • 7.3. Market Revenue, by Class (2017-2030)
    • 7.3.1. Class I market revenue, by type (2017-2030)
    • 7.3.2. Class II market revenue, by type (2017-2030)
    • 7.3.3. Class III market revenue, by type (2017-2030)
  • 7.4. Market Revenue, by Application (2017-2030)
  • 7.5. Market Revenue, by End User (2017-2030)
  • 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
  • 8.3. Market Revenue, by Class (2017-2030)
    • 8.3.1. Class I market revenue, by type (2017-2030)
    • 8.3.2. Class II market revenue, by type (2017-2030)
    • 8.3.3. Class III market revenue, by type (2017-2030)
  • 8.4. Market Revenue, by Application (2017-2030)
  • 8.5. Market Revenue, by End User (2017-2030)
  • 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
  • 9.3. Market Revenue, by Class (2017-2030)
    • 9.3.1. Class I market revenue, by type (2017-2030)
    • 9.3.2. Class II market revenue, by type (2017-2030)
    • 9.3.3. Class III market revenue, by type (2017-2030)
  • 9.4. Market Revenue, by Application (2017-2030)
  • 9.5. Market Revenue, by End User (2017-2030)
  • 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
  • 10.3. Market Revenue, by Class (2017-2030)
    • 10.3.1. Class I market revenue, by type (2017-2030)
    • 10.3.2. Class II market revenue, by type (2017-2030)
    • 10.3.3. Class III market revenue, by type (2017-2030)
  • 10.4. Market Revenue, by Application (2017-2030)
  • 10.5. Market Revenue, by End User (2017-2030)
  • 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
  • 11.3. Market Revenue, by Class (2017-2030)
    • 11.3.1. Class I market revenue, by type (2017-2030)
    • 11.3.2. Class II market revenue, by type (2017-2030)
    • 11.3.3. Class III market revenue, by type (2017-2030)
  • 11.4. Market Revenue, by Application (2017-2030)
  • 11.5. Market Revenue, by End User (2017-2030)
  • 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
  • 12.3. Market Revenue, by Class (2017-2030)
    • 12.3.1. Class I market revenue, by type (2017-2030)
    • 12.3.2. Class II market revenue, by type (2017-2030)
    • 12.3.3. Class III market revenue, by type (2017-2030)
  • 12.4. Market Revenue, by Application (2017-2030)
  • 12.5. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
  • 13.3. Market Revenue, by Class (2017-2030)
    • 13.3.1. Class I market revenue, by type (2017-2030)
    • 13.3.2. Class II market revenue, by type (2017-2030)
    • 13.3.3. Class III market revenue, by type (2017-2030)
  • 13.4. Market Revenue, by Application (2017-2030)
  • 13.5. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
  • 14.3. Market Revenue, by Class (2017-2030)
    • 14.3.1. Class I market revenue, by type (2017-2030)
    • 14.3.2. Class II market revenue, by type (2017-2030)
    • 14.3.3. Class III market revenue, by type (2017-2030)
  • 14.4. Market Revenue, by Application (2017-2030)
  • 14.5. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
  • 15.3. Market Revenue, by Class (2017-2030)
    • 15.3.1. Class I market revenue, by type (2017-2030)
    • 15.3.2. Class II market revenue, by type (2017-2030)
    • 15.3.3. Class III market revenue, by type (2017-2030)
  • 15.4. Market Revenue, by Application (2017-2030)
  • 15.5. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
  • 16.3. Market Revenue, by Class (2017-2030)
    • 16.3.1. Class I market revenue, by type (2017-2030)
    • 16.3.2. Class II market revenue, by type (2017-2030)
    • 16.3.3. Class III market revenue, by type (2017-2030)
  • 16.4. Market Revenue, by Application (2017-2030)
  • 16.5. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
  • 17.3. Market Revenue, by Class (2017-2030)
    • 17.3.1. Class I market revenue, by type (2017-2030)
    • 17.3.2. Class II market revenue, by type (2017-2030)
    • 17.3.3. Class III market revenue, by type (2017-2030)
  • 17.4. Market Revenue, by Application (2017-2030)
  • 17.5. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
  • 18.3. Market Revenue, by Class (2017-2030)
    • 18.3.1. Class I market revenue, by type (2017-2030)
    • 18.3.2. Class II market revenue, by type (2017-2030)
    • 18.3.3. Class III market revenue, by type (2017-2030)
  • 18.4. Market Revenue, by Application (2017-2030)
  • 18.5. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
  • 19.3. Market Revenue, by Class (2017-2030)
    • 19.3.1. Class I market revenue, by type (2017-2030)
    • 19.3.2. Class II market revenue, by type (2017-2030)
    • 19.3.3. Class III market revenue, by type (2017-2030)
  • 19.4. Market Revenue, by Application (2017-2030)
  • 19.5. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
  • 20.3. Market Revenue, by Class (2017-2030)
    • 20.3.1. Class I market revenue, by type (2017-2030)
    • 20.3.2. Class II market revenue, by type (2017-2030)
    • 20.3.3. Class III market revenue, by type (2017-2030)
  • 20.4. Market Revenue, by Application (2017-2030)
  • 20.5. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
  • 21.3. Market Revenue, by Class (2017-2030)
    • 21.3.1. Class I market revenue, by type (2017-2030)
    • 21.3.2. Class II market revenue, by type (2017-2030)
    • 21.3.3. Class III market revenue, by type (2017-2030)
  • 21.4. Market Revenue, by Application (2017-2030)
  • 21.5. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
  • 22.3. Market Revenue, by Class (2017-2030)
    • 22.3.1. Class I market revenue, by type (2017-2030)
    • 22.3.2. Class II market revenue, by type (2017-2030)
    • 22.3.3. Class III market revenue, by type (2017-2030)
  • 22.4. Market Revenue, by Application (2017-2030)
  • 22.5. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
  • 23.3. Market Revenue, by Class (2017-2030)
    • 23.3.1. Class I market revenue, by type (2017-2030)
    • 23.3.2. Class II market revenue, by type (2017-2030)
    • 23.3.3. Class III market revenue, by type (2017-2030)
  • 23.4. Market Revenue, by Application (2017-2030)
  • 23.5. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
  • 24.3. Market Revenue, by Class (2017-2030)
    • 24.3.1. Class I market revenue, by type (2017-2030)
    • 24.3.2. Class II market revenue, by type (2017-2030)
    • 24.3.3. Class III market revenue, by type (2017-2030)
  • 24.4. Market Revenue, by Application (2017-2030)
  • 24.5. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
  • 25.3. Market Revenue, by Class (2017-2030)
    • 25.3.1. Class I market revenue, by type (2017-2030)
    • 25.3.2. Class II market revenue, by type (2017-2030)
    • 25.3.3. Class III market revenue, by type (2017-2030)
  • 25.4. Market Revenue, by Application (2017-2030)
  • 25.5. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
  • 26.3. Market Revenue, by Class (2017-2030)
    • 26.3.1. Class I market revenue, by type (2017-2030)
    • 26.3.2. Class II market revenue, by type (2017-2030)
    • 26.3.3. Class III market revenue, by type (2017-2030)
  • 26.4. Market Revenue, by Application (2017-2030)
  • 26.5. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
  • 27.3. Market Revenue, by Class (2017-2030)
    • 27.3.1. Class I market revenue, by type (2017-2030)
    • 27.3.2. Class II market revenue, by type (2017-2030)
    • 27.3.3. Class III market revenue, by type (2017-2030)
  • 27.4. Market Revenue, by Application (2017-2030)
  • 27.5. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
  • 28.3. Market Revenue, by Class (2017-2030)
    • 28.3.1. Class I market revenue, by type (2017-2030)
    • 28.3.2. Class II market revenue, by type (2017-2030)
    • 28.3.3. Class III market revenue, by type (2017-2030)
  • 28.4. Market Revenue, by Application (2017-2030)
  • 28.5. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Acelity L.P. Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. MiMedx Group Inc.
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Organogenesis Inc.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Vericel Corporation
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. FUJIFILM Cellular Dynamics Inc.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Smith & Nephew plc
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Integra LifeSciences Holdings Corporation
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. AlloSource
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. MatTek Corporation
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!